-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MN2bqjSirhFlSFjNrQzLmP9J9w5KhHp+R28321TAapeVUeFjmADuF8SUziWOezuY nNtSrJmHzhEHJy61aFoktA== 0000950159-09-002060.txt : 20091116 0000950159-09-002060.hdr.sgml : 20091116 20091116101422 ACCESSION NUMBER: 0000950159-09-002060 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090930 FILED AS OF DATE: 20091116 DATE AS OF CHANGE: 20091116 EFFECTIVENESS DATE: 20091116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEERFIELD MANAGEMENT CO /NY CENTRAL INDEX KEY: 0001009258 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05366 FILM NUMBER: 091184172 BUSINESS ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125511600 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 deerfield13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2009 Check here if Amendment [ ]; Amendment Number: ----------- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Deerfield Management Company, LP Address: 780 Third Avenue, 37th Floor New York, NY 10017 Form 13F File Number: 28-5366 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Flynn Management LLC, its general partner Name: James E. Flynn Title: Managing Member Phone: 212-551-1600 Signature, Place, and Date of Signing: /s/ James E. Flynn New York, NY 11/16/09 - ------------------- --------------- ------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager is reported in this report and a portion is reported by other reporting manager(s).)
TITLE OF VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP x($1000) PRN AMT PRN CALL DISCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- ------- -------- --------- ------- ------ ------- AMERISOURCEBERGEN CORP COM 03073E105 27,059 1,208,000 SH DEFINED 01 10,000 AMGEN INC COM 031162100 3,313 55,000 SH DEFINED 01 55,000 AMGEN INC NOTE 0.125% 2/0 031162AN0 9,975 10,000,000 PRN DEFINED 01 10,000,000 AMICAS INC COM 001712108 1,964 545,688 SH DEFINED 01 545,688 AMYLIN PHARMACEUTICALS INC NOTE 2.500% 4/1 032346AD0 14,880 16,000,000 PRN DEFINED 01 16,000,000 ANGIODYNAMICS INC COM 03475V101 6,890 500,000 SH DEFINED 01 500,000 ANTARES PHARMA INC COM 036642106 4,163 3,750,000 SH DEFINED 01 3,750,000 AP PHARMA INC COM NEW 00202J203 1,705 2,006,147 SH DEFINED 01 2,006,147 ARDEA BIOSCIENCES INC COM 03969P107 4,311 235,293 SH DEFINED 01 235,293 ARQULE INC COM 04269E107 3,338 735,158 SH DEFINED 01 735,158 ARRAY BIOPHARMA INC COM 04269X105 10,943 4,597,846 SH DEFINED 01 4,597,846 ATS MED INC NOTE 6.000% 10/1 002083AB9 3,920 4,000,000 PRN DEFINED 01 4,000,000 AUXILIUM PHARMACEUTICALS INC COM 05334D107 6,798 198,706 SH DEFINED 01 198,706 BIOSPHERE MEDICAL INC COM 09066V103 3,744 1,098,061 SH DEFINED 01 1,098,061 CAPITAL SR LIVING CORP COM 140475104 1,668 273,451 SH DEFINED 01 273,451 CEPHALON INC NOTE 2.500% 5/0 156708AR0 15,207 14,500,000 PRN DEFINED 01 14,500,000 CIGNA CORP COM 125509109 12,921 460,000 SH DEFINED 01 460,000 CONCEPTUS INC NOTE 2.250% 2/1 206016AA5 7,359 7,850,000 PRN DEFINED 01 7,850,000 CONMED CORP NOTE 2.500% 11/1 207410AD3 12,819 14,126,000 PRN DEFINED 01 14,126,000 CUBIST PHARMACEUTICALS INC NOTE 2.250% 6/1 229678AC1 2,816 3,000,000 PRN DEFINED 01 3,000,000 CYTOKINETICS INC COM 23282W100 6,960 1,315,700 SH DEFINED 01 1,315,700 DENDREON CORP COM 24823Q107 16,814 600,700 PUT DEFINED 01 600,700 DIALYSIS CORP AMER COM 252529102 4,671 775,957 SH DEFINED 01 775,957 DIGIRAD CORP COM 253827109 912 320,000 SH DEFINED 01 320,000 DURECT CORP COM 266605104 3,738 1,400,000 SH DEFINED 01 1,400,000 DUSA PHARMACEUTICALS INC COM 266898105 3,288 3,016,965 SH DEFINED 01 3,016,965 ECLIPSYS CORP COM 278856109 10,133 525,000 SH DEFINED 01 525,000 ENDO PHARMA HLDGS NOTE 1.750% 4/1 29264FAA4 7,750 8,000,000 PRN DEFINED 01 8,000,000 EXPRESS SCRIPTS INC COM 302182100 20,559 265,000 SH DEFINED 01 265,000 GIVEN IMAGING ORD SHS M52020100 3,728 250,000 SH DEFINED 01 250,000 HALOZYME THERAPEUTICS INC COM 40637H109 18,440 2,593,567 SH DEFINED 01 2,593,567 HEARTWARE INTL INC COM 422368100 13,632 454,545 SH DEFINED 01 454,545 HUMAN GENOME SCIENCES INC COM 444903108 17,691 940,000 PUT DEFINED 01 940,000 HUMANA INC COM 444859102 13,428 360,000 SH DEFINED 01 360,000 INCYTE CORP COM 45337C102 3,375 500,000 SH DEFINED 01 500,000 INSPIRE PHARMACEUTICALS INC COM 457733103 28,820 5,521,011 SH DEFINED 01 5,521,011 INSULET CORP COM 45784P101 9,477 843,905 SH DEFINED 01 843,905 INTERMUNE INC COM 45884X103 23,332 1,464,663 SH DEFINED 01 1,464,663 INTERMUNE INC COM 45884X103 11,151 700,000 CALL DEFINED 01 700,000 INTERMUNE INC NOTE 0.250% 3/0 45884XAC7 5,081 5,000,000 PRN DEFINED 01 5,000,000 ISTA PHARMACEUTICALS INC COM NEW 45031X204 13,521 3,031,718 SH DEFINED 01 3,031,718 JAVELIN PHARMACEUTICALS INC COM 471894105 25 12,854 SH DEFINED 01 12,854 MAGELLAN HEALTH SERVICES INC COM NEW 559079207 19,878 640,000 SH DEFINED 01 640,000 MCKESSON CORP COM 58155Q103 34,182 574,000 SH DEFINED 01 574,000 MEDICINES CO COM 584688105 47,435 4,308,372 SH DEFINED 01 4,308,372 MEDICIS PHARMACEUTICAL CORP NOTE 2.500% 6/0 58470KAA2 15,699 16,439,000 PRN DEFINED 01 16,439,000 MEDTRONIC INC COM 585055106 32,200 875,000 SH DEFINED 01 875,000 MEDTRONIC INC NOTE 1.500% 4/1 585055AL0 19,577 19,700,000 PRN DEFINED 01 19,700,000 MEDTRONIC INC NOTE 1.620% 4/1 585055AM8 23,670 24,000,000 PRN DEFINED 01 24,000,000 MERCK & CO INC COM 589331107 21,192 670,000 SH DEFINED 01 670,000 NEUROGESX INC COM 641252101 7,556 944,499 SH DEFINED 01 944,499 NEUROMETRIX INC COM 641255104 14,104 4,393,673 SH DEFINED 01 4,393,673 NXSTAGE MEDICAL INC COM 67072V103 29,160 4,358,781 SH DEFINED 01 4,358,781 ONYX PHARMACEUTICALS INC COM 683399109 16,895 563,738 SH DEFINED 01 563,738 PAR PHARMACEUTICAL COS INC COM 69888P106 50,758 2,359,752 SH DEFINED 01 2,359,752 PFIZER INC COM 717081103 31,776 1,920,000 SH DEFINED 01 1,920,000 PHARMASSET INC COM 71715N106 23,459 1,109,699 SH DEFINED 01 1,109,699 QUIDEL CORP COM 74838J101 14,202 875,000 PUT DEFINED 01 875,000 RADNET INC COM 750491102 9,179 3,544,000 SH DEFINED 01 3,544,000 RES-CARE INC COM 760943100 3,124 219,852 SH DEFINED 01 219,852 RIGEL PHARMACEUTICALS INC COM NEW 766559603 24,020 2,929,266 SH DEFINED 01 2,929,266 ROCKWELL MEDICAL TECH COM 774374102 6,801 874,194 SH DEFINED 01 874,194 SALIX PHARMACEUTICALS INC COM 795435106 88,474 4,161,518 SH DEFINED 01 4,161,518 SEPRACOR INC COM 817315104 24,468 1,068,466 SH DEFINED 01 1,068,466 SEPRACOR INC COM 817315104 11,381 497,000 CALL DEFINED 01 497,000 SEPRACOR INC NOTE 10/1 817315AW4 13,964 14,052,000 PRN DEFINED 01 14,052,000 SEPRACOR INC NOTE 12/1 817315AU8 17,362 17,582,000 PRN DEFINED 01 17,582,000 SHIRE PLC SPONSORED ADR 82481R106 5,229 100,000 SH DEFINED 01 100,000 SPECTRANETICS CORP COM 84760C107 5,769 900,000 SH DEFINED 01 900,000 SUNESIS PHARMACEUTICALS INC COM 867328502 264 668,264 SH DEFINED 01 668,264 UNITEDHEALTH GROUP INC COM 91324P102 15,024 600,000 PUT DEFINED 01 600,000 UNIVERSAL AMERICAN CORP COM 913377107 7,206 765,000 SH DEFINED 01 765,000 VALEANT PHARMACEUTICALS INTL COM 91911X104 9,369 333,900 PUT DEFINED 01 333,900 WYETH COM 983024100 7,287 150,000 SH DEFINED 01 150,000 ZYMOGENETICS INC COM 98985T109 30,049 4,975,036 SH DEFINED 01 4,975,036 75 1,073,032
FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 75 Form 13F Information Table Value Total: $1,073,032 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] No. Form 13F File Number Name 01 28-11827 Flynn Management LLC -----END PRIVACY-ENHANCED MESSAGE-----